- Select a community
- MS
-
Find out more about the PatientsLikeMe
MS Community
Daclizumab Treatment Report
Most Popular Brands: Zenapax
What is Daclizumab?
This is an immunosuppresant, used to prevent organ rejection in kidney transplant cases. It has also been tested in clinical trials as a treatment for Multiple Sclerosis. Dosing is calculated based on weight and purpose of treatment. More info at: http://www.pdl.com/index.cfm?navId=49
Read more...
Reasons taken & Efficacy
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Multiple Sclerosis MS | 5 |
|
|
|
3 | ||
| Drug trial for MS | 2 |
|
|
2 | |||
| disease-related symptoms | 1 | 0 |
See all 3 patients currently taking Daclizumab
Mouse over the table for more information
Side Effects
Dosages
| 1 other monthly | ||
|---|---|---|
1
|
||
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
4 | 67% |
|
|
Did not seem to work
|
3 | 50% |
|
|
Doctor's advice
|
2 | 33% |
|
|
Change in health plan coverage
|
1 | 17% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 5 patient evaluations
-
- truthwillout
- Sex: F
- Sensation: Moderate
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: mild
- Walking: moderate
- See profile
-
-
- truthwillout
- 1 other monthly
- since Feb 16, 2010
-
Efficacy
Major
for Drug trial for MS
-
Side Effects
None
- Advice/Tips I really hope this drug makes it onto the market. I turned to Daclizumab as an off-label treatment for MS three years ago, and as far as I know have experien... See full evaluation
-
- edawgg
- Sex: F
- Sensation: Mild
- Overall: None
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: none
- See profile
-
-
- edawgg
- since Jan 12, 2010
-
Efficacy
Major
for Multiple Sclerosis MS
-
Side Effects
None
- See full evaluation
-
- LSK
- Sex: F
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: none
- Speech: moderate
- Swallowing: mild
- Upper limb: mild
- Walking: moderate
- See profile
-
-
- LSK
- 60 mg monthly
- since Mar 01, 2006
-
Efficacy
Slight
for Multiple Sclerosis MS
-
Side Effects
None
- See full evaluation
See all 5 patient evaluations
Report created on March 21, 2010.